✦ LIBER ✦

A533 RAD001: Phase II Trial in Relapsed/Refractory Waldenström Macroglobulinemia, the DFCI Experience

✍ Scribed by Ghobrial, IM; Roccaro, AM; Chuma, S; Sam, AP; Leduc, R; Nelson, M; O'Connor, K; Harris, B; Soumerai, J; Warren, D; Jacobsen, E; DeAngelo, D; Berg, W; Anderson, KC; Richardson, PG; Witzig, TE; Treon, SP

Book ID: 118629387
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 103 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70614-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A535 Phase II Trial of Bortezomib and Ri

A535 Phase II Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenström Macroglobulinemia

✍ Ghobrial, IM; Roccaro, AM; Matous, J; Padmanabhan, W; Badros, A; Schlossman, R; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 112 KB

A534 Perifosine: Final Results of a Phas

A534 Perifosine: Final Results of a Phase II Trial in Relapsed/Refractory Waldenström Macroglobulinemia

✍ Ghobrial, IM; Roccaro, AM; Sportelli, P; Treon, SP; Weller, E; Leleu, X; Rubin, 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 85 KB

Extended follow-up of a phase II trial i

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma: : Final time-to-event results from the SUMMIT trial

✍ Paul G. Richardson; Bart Barlogie; James Berenson; Seema Singhal; Sundar Jaganna 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

Phase II trial of the pan-deacetylase in

Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma

✍ Wolf, Jeffrey L.; Siegel, David; Goldschmidt, Hartmut; Hazell, Katharine; Bourqu 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 167 KB

Phase II trial of 2-chlorodeoxyadenosine

Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: A study of the Eastern Cooperative Oncology Group (ECOG), E5995

✍ Michael S Gordon; Molly L Young; Martin S Tallman; Larry D Cripe; John M Bennett 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Phase I/II trial of clofarabine and cyta

Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): A report from the Children's Oncology Group

✍ Cooper, Todd M.; Razzouk, Bassem I.; Gerbing, Robert; Alonzo, Todd A.; Adlard, K 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB